The shareholders of Klinipath BV, Mortupath BV and Immunologic BV have sold their complete share capital to the American VWR International, LLC.
This acquisition extends VWR’s capabilities and portfolio in histology, immunology and clinical chemistry across Europe.
Lindenaar & Co acted as advisor to the shareholders of Klinipath and her subsidiaries in the entire sale process, including the structuring of the transaction, negotiating the LoI, performing a company valuation analysis, coordination of the due diligence process, final negotiations and closing of the transaction.
Profile Klinipath
Klinipath and its affiliates are independent providers of equipment, consumables and reagents representing a number of leading suppliers for the histology, pathology, cytology, immunology and clinical chemistry industries in addition to private label equipment, reagents and plastic disposables marketed under the Klinipath and Immunologic brands.
Profile VWR International
VWR International, LLC, headquartered in Radnor, Pennsylvania, is a leading, independent provider of laboratory supplies, equipment and services to the global life science and research industries with worldwide sales in excess of $4.1 billion in 2013. VWR enables the advancement of the world's most critical research by providing product and service solutions to laboratories and production facilities in the pharmaceutical, biotech, industrial, educational, governmental and healthcare industries around the globe.